GW 583340 dihydrochloridePotent dual EGFR/ErbB2 inhibitor; orally active CAS# 1173023-85-2 |
- TAK-875
Catalog No.:BCC3702
CAS No.:1000413-72-8
- GSK1292263
Catalog No.:BCC3786
CAS No.:1032823-75-8
- GPR40 Activator 1
Catalog No.:BCC4125
CAS No.:1309435-60-6
- TUG-770
Catalog No.:BCC2018
CAS No.:1402601-82-4
- GW9508
Catalog No.:BCC1102
CAS No.:885101-89-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1173023-85-2 | SDF | Download SDF |
PubChem ID | 16219404 | Appearance | Powder |
Formula | C28H27Cl3FN5O3S2 | M.Wt | 671.03 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in DMSO with gentle warming | ||
Chemical Name | N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[2-[(2-methylsulfonylethylamino)methyl]-1,3-thiazol-4-yl]quinazolin-4-amine;dihydrochloride | ||
SMILES | CS(=O)(=O)CCNCC1=NC(=CS1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl.Cl.Cl | ||
Standard InChIKey | WIMITXDBYLKRKB-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C28H25ClFN5O3S2.2ClH/c1-40(36,37)10-9-31-14-27-35-25(16-39-27)19-5-7-24-22(12-19)28(33-17-32-24)34-21-6-8-26(23(29)13-21)38-15-18-3-2-4-20(30)11-18;;/h2-8,11-13,16-17,31H,9-10,14-15H2,1H3,(H,32,33,34);2*1H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Potent dual EGFR/ErbB2 tyrosine kinase inhibitor (IC50 values are 0.01 and 0.014 μM respectively). Selectively inhibits growth of human tumor cells overexpressing EGFR and ErbB2 (IC50 values are 0.11 μM for inhibition of HN5, N87 and BT474 tumor cell lines vs. > 30 μM for inhibition of non-tumor cell line HFF). Inhibits tumor growth in vivo by ~ 80% in a murine xenograft model following oral administration. |
GW 583340 dihydrochloride Dilution Calculator
GW 583340 dihydrochloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.4902 mL | 7.4512 mL | 14.9025 mL | 29.8049 mL | 37.2562 mL |
5 mM | 0.298 mL | 1.4902 mL | 2.9805 mL | 5.961 mL | 7.4512 mL |
10 mM | 0.149 mL | 0.7451 mL | 1.4902 mL | 2.9805 mL | 3.7256 mL |
50 mM | 0.0298 mL | 0.149 mL | 0.298 mL | 0.5961 mL | 0.7451 mL |
100 mM | 0.0149 mL | 0.0745 mL | 0.149 mL | 0.298 mL | 0.3726 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- STO-609 acetate
Catalog No.:BCC7112
CAS No.:1173022-21-3
- RS 102895 hydrochloride
Catalog No.:BCC7260
CAS No.:1173022-16-6
- gamma-secretase modulator 1
Catalog No.:BCC1583
CAS No.:1172637-87-4
- 8alpha-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate
Catalog No.:BCN1609
CAS No.:117254-98-5
- Soyasaponin Aa
Catalog No.:BCN2597
CAS No.:117230-33-8
- Taxacin
Catalog No.:BCN6950
CAS No.:117229-54-6
- HO-3867
Catalog No.:BCC5639
CAS No.:1172133-28-6
- PI3Kγ inhibitor 1
Catalog No.:BCC4180
CAS No.:1172118-03-4
- M 1145
Catalog No.:BCC6053
CAS No.:1172089-00-7
- Sophoraisoflavone A
Catalog No.:BCN6826
CAS No.:117204-81-6
- Boc-Ala(3-pyridyl)-OH
Catalog No.:BCC3322
CAS No.:117142-26-4
- Fmoc-N-Me-Thr(tBu)-OH
Catalog No.:BCC3354
CAS No.:117106-20-4
- U0126-EtOH
Catalog No.:BCC1066
CAS No.:1173097-76-1
- PKI-402
Catalog No.:BCC3843
CAS No.:1173204-81-3
- Clocinnamox mesylate
Catalog No.:BCC5684
CAS No.:117332-69-1
- Emeheterone
Catalog No.:BCN7285
CAS No.:117333-12-7
- 9,9-Bis[4-(2-hydroxyethoxy)phenyl]fluorene
Catalog No.:BCC8796
CAS No.:117344-32-8
- 2-Hydroxysaclofen
Catalog No.:BCC6579
CAS No.:117354-64-0
- AZD6482
Catalog No.:BCC2523
CAS No.:1173900-33-8
- Endothelin 3 (human, rat)
Catalog No.:BCC5713
CAS No.:117399-93-6
- Artoheterophyllin B
Catalog No.:BCN6050
CAS No.:1174017-37-8
- Dimethylwulignan A1
Catalog No.:BCN3624
CAS No.:117404-43-0
- AZD2461
Catalog No.:BCC2214
CAS No.:1174043-16-3
- 4-O-beta-Glucopyranosyl-cis-coumaric acid
Catalog No.:BCN1608
CAS No.:117405-48-8
Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.[Pubmed:12639547]
Bioorg Med Chem Lett. 2003 Feb 24;13(4):637-40.
We have identified a novel class of 6-thiazolylquinazolines as potent and selective inhibitors of both ErbB-2 and EGFR tyrosine kinase activity, with IC(50) values in the nanomolar range. These compounds inhibited the growth of both EGFR (HN5) and ErbB-2 (BT474) over-expressing human tumor cell lines in vitro. Using xenograft models of the same cell lines, we found that the compounds given orally inhibited in vivo tumor growth significantly compared with control animals.